Vaccines (Nov 2022)

COVID-19 and NSTEMI Outcomes among Hospitalized Patients in the United States and Racial Disparities in Mortality: Insight from National Inpatient Sample Database

  • Harris Majeed,
  • Karthik Gangu,
  • Shazib Sagheer,
  • Ishan Garg,
  • Umair Khan,
  • Hina Shuja,
  • Aniesh Bobba,
  • Prabal Chourasia,
  • Rahul Shekhar,
  • Sindhu Reddy Avula,
  • Abu Baker Sheikh

DOI
https://doi.org/10.3390/vaccines10122024
Journal volume & issue
Vol. 10, no. 12
p. 2024

Abstract

Read online

The COVID-19 pandemic has impacted healthcare delivery to patients with non-ST-segment elevation myocardial infraction (NSTEMI). The aim of our retrospective study is to determine the effect of COVID-19 on inpatient NSTEMI outcomes and to investigate whether changes in cardiac care contributed to the observed outcomes. After multivariate adjustment, we found that NSTEMI patients with COVID-19 had a higher rate of inpatient mortality (37.3% vs. 7.3%, adjusted odds ratio: 4.96, 95% CI: 4.6–5.4, p p p p p p < 0.001). In our study, we observed increased mortality and in-hospital complications to be a combined effect of COVID-19 infection and myocardial inflammation as a result of cytokine storm, prothrombic state, oxygen supply/demand imbalance and alterations in healthcare delivery from January to December 2020.

Keywords